BOKU - Universität für Bodenkultur Wien - Forschungsinformationssystem

Logo BOKU-Forschungsportal

Gewählte Publikation:

Calarese, DA; Lee, HK; Huang, CY; Best, MD; Astronomo, RD; Stanfield, RL; Katinger, H; Burton, DR; Wong, CH; Wilson, IA.
(2005): Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.
Proc Natl Acad Sci U S A. 2005; 102(38):13372-13377 FullText FullText_BOKU

Human antibody 2G12 neutralizes a broad range of HIV-1 isolates. Hence, molecular characterization of its epitope, which corresponds to a conserved cluster of oligomannoses on the viral envelope glycoprotein gp120, is a high priority in HIV vaccine design. A prior crystal structure of 2G12 in complex with Man(9)GIcNAc(2) highlighted the central importance of the 1311 arm in antibody binding. To characterize the specificity of 2G12 more precisely, we performed solution-phase ELISA, carbohydrate microarray analysis, and cocrystallized Fab 2G12 with four different oligomannose derivatives (Man(4), Man(5), Man(7), and Man(8)) that compete with gp120 for binding to 2G12. Our combined studies reveal that 2G12 is capable of binding both the D1 and D3 arms of the Man(9)GIcNAC(2) moiety, which would provide more flexibility to make the required multivalent interactions between the antibody and the gp120 oligomannose cluster than thought previously. These results have important consequences for the design of immunogens to elicit 2G12-like neutralizing antibodies as a component of an HIV vaccine.
Autor*innen der BOKU Wien:
Katinger Hermann
Find related publications in this database (using NML MeSH Indexing)
AIDS Vaccines - immunology
Antibodies, Monoclonal - chemistry
Binding Sites, Antibody - immunology
Carbohydrate Sequence -
Crystallography, X-Ray -
Epitopes - chemistry
HIV Antibodies - chemistry
HIV Envelope Protein gp120 - immunology
HIV-1 - chemistry
Mannose - chemistry
Molecular Sequence Data -
Oligosaccharides, Branched-Chain - chemistry

Find related publications in this database (Keywords)
2G12 antibody
HIV vaccine

© BOKU Wien Impressum